Cargando…
BET Bromodomain Degradation Disrupts Function but Not 3D Formation of RNA Pol2 Clusters
Fusion-positive rhabdomyosarcoma (FP-RMS) is driven by a translocation that creates the chimeric transcription factor PAX3-FOXO1 (P3F), which assembles de novo super enhancers to drive high levels of transcription of other core regulatory transcription factors (CRTFs). P3F recruits co-regulatory fac...
Autores principales: | Chin, Diana H., Osman, Issra, Porch, Jadon, Kim, Hyunmin, Buck, Kristen K., Rodriguez, Javier, Carapia, Bianca, Yan, Deborah, Moura, Stela B., Sperry, Jantzen, Nakashima, Jonathan, Altman, Kasey, Altman, Delsee, Gryder, Berkley E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966215/ https://www.ncbi.nlm.nih.gov/pubmed/37259348 http://dx.doi.org/10.3390/ph16020199 |
Ejemplares similares
-
Selective inhibition of BET bromodomains
por: Filippakopoulos, Panagis, et al.
Publicado: (2010) -
Targeting BET bromodomain proteins in solid tumors
por: Sahai, Vaibhav, et al.
Publicado: (2016) -
BET bromodomain proteins are required for glioblastoma cell proliferation
por: Pastori, Chiara, et al.
Publicado: (2014) -
When are the BET factors the most sensitive to bromodomain inhibitors?
por: Khochbin, Saadi
Publicado: (2013) -
Bromodomain Blockade for Intimal Hyperplasia — A Good BET?
por: Ostriker, Allison C., et al.
Publicado: (2015)